跳至主要内容
临床试验/NL-OMON32871
NL-OMON32871已完成3 期

The effect of vildagliptin on endothelium-dependent vasodilatation. A double blind, cross-over study in type 2 diabetes mellitus. - Vildagliptin and vasodilatation

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - type 2 diabetes
  • - age 35-75 years
  • - metformin monotherapy or combination therapy
  • - HbA1c < 8.0%

排除标准

  • - Renal disease defined as creatinine level > 130 umol/l
  • - Liver disease defined as aspartate aminotransferase or alanine aminotransferase level of more than three times the upper limit of normal range
  • - Current use of acetylsalicylic acid or vitamine K antagonists
  • - History of smoking within the past year
  • - History of or current abuse of drugs or alcohol
  • - History of heartfailure (NYHA class III or IV)
  • - Abnormalities on ECG that might interfere with current study protocol
  • - Pregnancy or breastfeeding
  • - Inability to understand the nature and extent of the trial and procedures required
  • - Presence of any medical condition that might interfere with the current study protocol
  • - Participation in a drug trial within 60 days prior to the first dose

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验